Overdose Detection Mapping Application Program (ODMAP) Data System Evaluation

The University of Kentucky (UK) will perform an independent evaluation of the Overdose Detection Mapping Application (ODMAP) data system using a generalizable framework for evaluating public health surveillance systems according to the US Centers for Disease Control and Prevention (CDC). The data-driven component of the evaluation will emphasize critical features of ODMAP such as the accuracy of the geocoding process, correlation of non-fatal overdose events with other key criminal justice and health outcomes (e.g., fatal overdoses) and signal detection approaches (working in collaboration with the Hopkins Applied Physics Lab). The ODMAP user-driven component of the evaluation will involve identifying up to 4 local sites around the country with varying degrees of ODMAP adoption and criminal justice and public health data availability to understand public safety and public health user preferences. UK will work closely with ODMAP leadership, analysts, users, and federal partners as appropriate to identify and answer open, existing questions related to ODMAP and novel questions that may arise during the evaluation. The following Scope describes the work UK will complete to evaluate ODMAP. Developed by the Washington/Baltimore High Intensity Drug Trafficking Area (HIDTA) program, ODMAP is an overdose mapping tool that allows first responders and other stakeholders to log an overdose in real time into a centralized database. The tool captures fatal and nonfatal overdose incidents and centralizes data relating to overdoses within one platform. Project Goal: The goal of this project is to increase the likelihood that the ODMAP platform, and/or the analytic files produced by ODMAP, is adopted and used by public safety and public health practitioners by documenting evidence of its strengths and limitations as a public health surveillance system. When possible and allowed, UK will submit reports for peer-review publications to build this empirical, evidence base.